GWCA0962/GWCA0958 Cancer Pain
This nine week study will aim to determine the efficacy, safety and tolerability of Sativex® as an adjunctive treatment, compared with placebo in relieving uncontrolled persistent chronic pain in patients with advance cancer.
o Treat pain in patients with advanced cancer that experience inadequate pain relief with currently available medications or have side effects with currently available medications.
o Patients must be 18 years old with no personal or family history of any psychotic illness, including but not limited to schizophrenia.
o Patient must be willing to call in pain scores and medication use to a toll-free number daily.